LLM hypothesis validated in lab suggests new path for breast cancer immunotherapy
allen_ai · x · 2026-08-28
Research shared by AllenAI validates a surprisal-driven LLM hypothesis in the lab. The findings suggest immunotherapy should be tested for invasive lobular carcinoma, a patient group currently excluded from large neoadjuvant immunotherapy trials.
More from Research
- Pathway CSO pitches BDH as post-Transformer architecture uniting memory, reasoning, adaptation — schwentker · 2026-10-15
- EmbodiedEvo tops RoboDojo at 38.95% success by letting robots inherit failed practice — thetripathi58 · 2026-10-15
- 797GB of n-gram counts in CPU RAM let 1B models match 57% more compute — PangWeiKoh · 2026-10-15
- Google's HARNESS² evolves agent harnesses without verifiers, up to +11.5 points on WorkBuddy-Bench — dair_ai · 2026-10-15
- Subbarao Kambhampati to dissect the 'mythos of LLM thinking tokens' at UMN — rao2z · 2026-10-15
- How 3D Gaussian Splatting gives robots spatial memory of what's out of view — TheTuringPost · 2026-10-15